Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

DYN Dyne Therapeutics Inc

31,25

-0,28 (-0,89%)

Zuletzt aktualisiert: 21:58:11

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Dyne Therapeutics (NASDAQ:DYN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Dyne Therapeutics Charts.

Dyne Therapeutics (NASDAQ:DYN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Dyne Therapeutics Charts.

News Dyne Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 23 Mai 2024 (19 Stunden vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Mittwoch 22 Mai 2024 (24 Stunden vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 22 Mai 2024 (1 Tag vor) • Edgar (US Regulatory)

Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
Mittwoch 22 Mai 2024 (2 Tage vor) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Dienstag 21 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Montag 20 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Dyne Therapeutics Announces Proposed Public Offering of Common Stock
Montag 20 Mai 2024 (3 Tage vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 20 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints
Montag 20 Mai 2024 (3 Tage vor) • GlobeNewswire Inc.

Dyne Therapeutics to Host Virtual Investor Event to Review New Clinical Data from the ACHIEVE and DELIVER Trials Tomorrow, May 20 at 8:00 a.m. ET
Sonntag 19 Mai 2024 (4 Tage vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 18 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 18 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Weitere Dyne Therapeutics Inc News-Artikel

Fidelity Digital Health ...

Evofem Biosciences (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen